NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding NextCure, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 17 | 24 | +7 |
| Shares | 858.1K | 1.90M | +1.04M (+121.1%) |
| Value | $5.03M | $26.9M | +$21.9M (+435.7%) |
New holders (9)
Institutions that held NextCure, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 238,303 | $3.38M | 0.44% |
| Squadron Capital Management LLC | 236,966 | $3.36M | 1.50% |
| Silverarc Capital Management, LLC | 176,057 | $2.50M | 0.36% |
| Exome Asset Management LLC | 165,000 | $2.34M | 1.16% |
| AWM Investment Company, Inc. | 117,371 | $1.67M | 0.16% |
| Boothbay Fund Management, LLC | 69,617 | $987.9K | 0.03% |
| Millennium Management LLC | 13,033 | $184.9K | 0.00% |
| Marshall Wace, LLP | 11,292 | $160.2K | 0.00% |
| Morgan Stanley | 66 | $937 | 0.00% |
Sold out (2)
Institutions that held NextCure, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cable Car Capital LLC | 63,178 | $370.2K |
| Citigroup Inc | 1 | $6 |